Supply of Cyclobenzaprine Hydrochloride Tablets

The contract entails the supply and delivery of FDA-compliant cyclobenzaprine hydrochloride tablets in commercial packaging complete with proper NDC coding, adhering strictly to Department of Defense unit-of-issue standards. The product must meet all regulatory and operational requirements for use within military healthcare systems, ensuring consistent quality, labeling, and traceability according to federal pharmaceutical guidelines. The award is issued under a subcontract and falls under NAICS code 325412, indicating pharmaceutical manufacturing as the primary classification. The Defense Logistics Agency, acting on behalf of the Department of Defense, is the contracting organization responsible for this procurement, with the performance location unspecified but understood to align with DLA supply chain logistics protocols. The contract was posted on August 5, 2026, and is accessible through the DIBBS portal using the provided contract and delivery identifiers, confirming it is part of an active procurement cycle for essential pharmacological supplies. The terms require full compliance with DoD inventory and distribution norms, emphasizing readiness and reliability for service-wide medical support.